Vaccine: its application and development
Yamane, N.
Rinsho Byori. Japanese Journal of Clinical Pathology 34(1): 31-37
1986
ISSN/ISBN: 0047-1860 PMID: 2422411 Document Number: 278835
Document emailed within 1 workday
Related Documents
Rerks-Ngarm, S.; Pitisuttithum, P.; Ganguly, N.; Zhang, L.; Tamashiro, H.; Cooper, D.A.; Vun, M.Chhi.; Bela, B.; Ditangco, R.; Van Kinh, N.; Bernstein, A.; Osmanov, S.; Mathieson, B.; Kent, S.J.; Shao, Y. 2010: Defining the objectives of the AIDS vaccine for Asia network: report of the WHO-UNAIDS/Global HIV vaccine enterprise regional consultation on expanding AIDS vaccine research and development capacity in Asia Current Opinion in HIV and Aids 5(5): 435-452Rerks-Ngarm, S.; Pitisuttithum, P.; Ganguly, N.; Zhang, L.; Tamashiro, H.; Cooper, D.A.; Vun, M.Chhi.; Bela, B.; Ditangco, R.; Van Kinh, N.; Bernstein, A.; Osmanov, S.; Mathieson, B.; Kent, S.J.; Shao, Y. 2010: Defining the objectives of the AIDS vaccine for Asia network: report of the WHO-UNAIDS/Global HIV vaccine enterprise regional consultation on expanding AIDS vaccine research and development capacity in Asia Current Opinion in HIV and Aids 5(5): 435-452
Rerks-Ngarm, S.; Pitisuttithum, P.; Ganguly, N.; Zhang, L.; Tamashiro, H.; Cooper, D.A.; Vun, M.Chhi.; Bela, B.; Ditangco, R.; Van Kinh, N.; Bernstein, A.; Osmanov, S.; Mathieson, B.; Kent, S.J.; Shao, Y. 2010: Defining the objectives of the AIDS vaccine for Asia network: report of the WHO-UNAIDS/Global HIV vaccine enterprise regional consultation on expanding AIDS vaccine research and development capacity in Asia Current Opinion in HIV and Aids 5(5): 435-452
Mayr, A. 2001: Development of of non-immunising, paraspecific vaccine from attenuated pox viruses: a new type of vaccine Berliner und Munchener Tierarztliche Wochenschrift 114(5-6): 184-187
Akahane, Y. 1981: Development of research on B-type hepatitis virus vaccine---including HBs antigen polypeptide vaccine Nihon Rinsho. Japanese Journal of Clinical Medicine 39(3): 619-630
Ford, A.Q.; Touchette, N.; Hall, B.Fenton.; Hwang, A.; Hombach, J. 2016: Global Vaccine and Immunization Research Forum: Opportunities and challenges in vaccine discovery, development, and delivery Vaccine 34(13): 1489-1495
Oxford, J.S.; Jeffs, S.A. 1996: New scientific developments towards an AIDS vaccine: report on a workshop organized by EU programme EVA entitled Novel approaches to AIDS vaccine development held at the Institut Pasteur, Paris. 16-17 November 1995 Vaccine 14(17-18): 1712-1717
Oxford, J.S.; Jeffs, S.A. 1996: New scientific developments towards an AIDS vaccine: report on a workshop organized by EU programme EVA entitled Novel approaches to AIDS vaccine development held at the Institut Pasteur, Paris. 16-17 November 1995 Vaccine 14(17-18): 1712-1717
Nakada, S. 1987: New technology of vaccine production--international prospect of the development--subunit vaccine obtained by genetic engineering. b. Genetic engineering method using animal cells Nihon Rinsho. Japanese Journal of Clinical Medicine 45(10): 2326-2332
Bobath, B. 1971: Motor development, its effect on general development, and application to the treatment of cerebral palsy PhysioTherapy 57(11): 526-532
Romanov, G.I. 1980: Preparation, control and application of anthrax vaccine in USSR Archiv für Experimentelle Veterinarmedizin 34(1): 119-122
Benyeda, J.; Mocsári, E. 1974: Application of an attenuated virus containing TGE vaccine; the relationship of antibody level and immunity Developments in Biological Standardization 26: 33-37
Makino, S.; Sasaki, K.; Nakamura, N.; Nakagawa, M.; Nakajima, S. 1974: Studies on the modification of the live AIK measles vaccine. II. Development and evaluation of the live AIK-C measles vaccine Kitasato Archives of Experimental Medicine 47(1-2): 13-21
Rondinini, B. 1965: Trends and Results of Application of Prophylactic Antitubercular Vaccination with the Salvioli's Diffusing Vaccine (S.D.V.) Minerva Medica 56: 1079-1080
Izawa, T.; Ihara, T.; Hattori, A.; Iwasa, T.; Kamiya, H.; Sakurai, M.; Takahashi, M. 1977: Application of a live varicella vaccine in children with acute leukemia or other malignant diseases Pediatrics 60(6): 805-809
Halperin, G.; Marcus, H. 2001: Application of recovery tests in the validation of immunoassays for assessing the immunogenicity of B. anthracis PA vaccine PDA Journal of Pharmaceutical Science and Technology 55(3): 150-161
Hejtmánek, M.; Kolousek, R.; Weigl, E.; Rybnikár, A.; Vrzal, V.; Chumela, J. 1986: Tissue reaction in guinea pigs after intramuscular application of living vaccine against trichophytosis Acta Universitatis Palackianae Olomucensis Facultatis Medicae 114: 171-185
Bognár, K. 1974: Experiences in the production control and field application of vaccine and serum against bovine virus diarrhea in Hungary Developments in Biological Standardization 26: 19-24
El'shina, G.A.; Sumarokov, A.A.; Anisimova, T.I.; Dranovskaia, E.A.; Saiapina, L.V.; Adamova, G.V.; Bekzatov, K.N.; Varlamov, N.N.; Sidorenko, S.V. 1991: A safety and reactogenicity study of experimentally produced batches of the brucellosis chemical vaccine with different methods for its application Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 9: 50-53
Miura, S. 1968: Effects of the combined administration of a triple vaccine of pertussis, diphtheria and tetanus and virus vaccine (live polio vaccine or inactivated measles vaccine) on immunity to pertussis, diphtheria and tetanus. 1. Results of the initial immunization Nihon Shonika Gakkai Zasshi. Acta Paediatrica Japonica 72(6): 767-781